Home Overview Press Room Blog Publications For Students about us
Search

Personal genomics : Displaying 230-249 of 906


165,000 Engagements End Due to ‘Genetic Incompatibilities’by Hussain Hazzazi and Ayman Al-SaidalaniSaudi GazetteMarch 24th, 2015In Saudi Arabia, health checkups are mandatory for engaged couples before they get married. The program aims to reduce the risk of having children with any blood or gastronomical diseases.
These Are All the Things That Could Go Wrong with 23andMe's Drug Development[Quotes CGS's Marcy Darnovsky]by Kari PaulMotherboardMarch 19th, 201523andMe will begin using its DNA database to develop new medical treatments. Experts question what that means for the 850,000 people who have submitted their data to the company.
Public interest group condemns human germline modification efforts, supports research moratorium, calls for US prohibition[Press Statement]March 19th, 2015We're at a watershed moment in determining whether human genetic technologies will be used in the public interest and for the common good, or in ways that are dangerous and socially pernicious.
Universal Newborn Genome Sequencing and Generation Alphaby Ricki Lewis, Biopolitical Times guest contributorMarch 16th, 2015What might the future look like, as whole-genome sequencing of newborns ramps up?
California and your DNA: Is it a healthy relationship? by Jessica CussinsBiopolitical TimesMarch 16th, 2015While every state across the country takes part in newborn screening, each state differs in how it handles the blood cards and the genetic information they hold. In California, those cards are stored indefinitely and potentially rented out for a broad array of uses.
How Identity Evolves in the Age of Genetic Imperialismby Eleonore Pauwels and Jim DratwaScientific AmericanMarch 13th, 2015The Silicon Valley brand of genetic determinism tells us there is a gene-hack to solve every “problem” — that DNA is just a code to personalize at will.
Get Genetic Testing and Cheat the System?by Robert KlitzmanCNNMarch 13th, 2015Many people undergo genetic testing on their own and pay out of pocket, allowing them to keep the result to themselves.
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitionsby Alex LashXconomyMarch 12th, 2015"We definitely think genetics should be married with all the other info being tracked. That will come in time."
23andMe to Use Genetic Database for Drug Discoveryby Ron WinslowWall Street JournalMarch 12th, 201523andMe's new therapeutics group, led by a star drug developer, will have "the opportunity to look broadly through the database and not have a particular restriction to what we’re looking for."
Privacy and the 100,000 Genome Projectby Edward Hockings and Lewis CoyneThe GuardianMarch 10th, 2015As the Department of Health starts to draw a map of thousands of genomes, will it keep its promise to anonymize our data?
Genetic Testing Ads Not Telling the Whole Story, Study Saysby Sabriya RiceModern HealthcareMarch 6th, 2015"There are very important limitations...but they are not widely reported on websites that market personalized cancer care."
Pregnant Women Are Finding Out They Have Cancer From A Genetic Test Of Their Babiesby Virginia HughesBuzzFeedMarch 5th, 2015When it comes to prenatal tests, it’s not clear whether incidental findings have clear-cut diagnostic value. And false positives might spur a pregnant woman to go through unnecessary medical procedures.
Supreme Court Gives Tacit Approval for Government to Take Anybody’s DNAby David KravetsArs TechnicaMarch 2nd, 2015The Supreme Court has let stand the conviction of a rapist whose prosecution rested on DNA swiped from the armrests of an interrogation-room chair.
23andMe’s Dangerous Business Modelby Marcy DarnovskyThe New York TimesMarch 2nd, 2015Handing over reams of our genetic, health and personal information to companies like 23andMe – and paying them for the privilege – is far from the only path to scientific advance.
Anne Wojcicki’s Quest to Put People in Charge of Their Own Health[Quotes CGS's Marcy Darnovsky]by Stephanie LeeSan Francisco ChronicleFebruary 28th, 201523andMe has attracted nearly a million customers and more than $126 million in venture capital, but not everyone thinks it should be the one to collect their data.
Building a Face, and a Case, on DNAby Andrew PollackThe New York TimesFebruary 23rd, 2015Rather than an artist’s rendering based on witness descriptions, the face was generated by a computer relying solely on DNA found at the scene of the crime.
The 23andMe Experience - A Lot of Knowledge is of Little Help?by Alison LashwoodBioNewsFebruary 23rd, 2015Those in favour see direct-to-consumer genetic tests as a way of engaging the public with science and making it fun, but there are problematic aspects, too.
US Regulators Try to Tame 'Wild West' of DNA Testingby Erika Check HaydenNature NewsFebruary 20th, 2015A particular sticking point is who decides what the genetic read-outs mean in terms of health and disease.
FDA Clearance of DTC Genetic Test Gets Mixed Reviewsby Ricki LewisMedscsape February 20th, 2015The FDA has authorized 23andMe to market a direct-to-consumer carrier test for Bloom syndrome.
Reading Our Genome is Tough, But Epigenetics is Giving Us Valuable Cluesby Marcus WooWiredFebruary 19th, 2015If the genome is a book, then the epigenome is like the post-it notes, dog-ears, and highlights that help you make sense of a particularly dense text.
Displaying 230-249 of 906  
< Prev  Next >> 
« First Page Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760